Pozzilli, Carlo

Defining the clinical course of multiple sclerosis: The 2013 revisions

Lublin, F. D., Reingold, S. C., Cohen, J. A., Cutter, G. R., Sørensen, P. S., Thompson, A. J., Wolinsky, J. S., Balcer, L. J., Banwell, B., Barkhof, F., et al. (2014) · Neurology

Multiple Sclerosis Research StudiesPsoriasis: Treatment and Pathogenesis

Cited by 3,177

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis: Sativex for refractory spasticity in MS

Novotna, A., Mares, J., Ratcliffe, S., Novakova, I., Vachova, M., Zapletalova, O., Gasperini, C., Pozzilli, C., Cefaro, L., Comi, G., et al. (2011) · European Journal of Neurology

Botulinum Toxin and Related Neurological DisordersMultiple Sclerosis Research Studies

Cited by 475

Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial

Kappos, L., Fox, R. J., Burcklen, M., Freedman, M. S., Havrdová, E. K., Hennessy, B., Hohlfeld, R., Lublin, F., Montalban, X., Pozzilli, C., et al. (2021) · JAMA Neurology

Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling

Cited by 228

‘Gender gap’ in multiple sclerosis: magnetic resonance imaging evidence

Pozzilli, C., Tomassini, V., Marinelli, F., Paolillo, A., Gasperini, C., & Bastianello, S. (2003) · European Journal of Neurology

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 154

Psychopathological and Cognitive Effects of Therapeutic Cannabinoids in Multiple Sclerosis: A Double-Blind, Placebo Controlled, Crossover Study

Aragona, M., Onesti, E., Tomassini, V., Conte, A., Gupta, S., Gilio, F., Pantano, P., Pozzilli, C., & Inghilleri, M. (2009) · Clinical Neuropharmacology

Cannabis and Cannabinoid ResearchMultiple Sclerosis Research Studies

Cited by 109

Cannabinoid‐induced effects on the nociceptive system: A neurophysiological study in patients with secondary progressive multiple sclerosis

Conte, A., Bettolo, C. M., Onesti, E., Frasca, V., Iacovelli, E., Gilio, F., Giacomelli, E., Gabriele, M., Aragona, M., Tomassini, V., et al. (2009) · European Journal of Pain

Cannabis and Cannabinoid ResearchPain Mechanisms and Treatments

Cited by 62

Alexithymia in multiple sclerosis: Relationship with fatigue and depression

Bodini, B., Mandarelli, G., Tomassini, V., Tarsitani, L., Pestalozza, I., Gasperini, C., Lenzi, G. L., Pancheri, P., & Pozzilli, C. (2008) · Acta Neurologica Scandinavica

Psychosomatic Disorders and Their TreatmentsMultiple Sclerosis Research Studies

Cited by 59

The role of microglia in multiple sclerosis: implications for treatment with Bruton’s tyrosine kinase inhibitors

Vermersch, P., Airas, L., Berger, T., Deisenhammer, F., Grigoriadis, N., Hartung, H.-P., Magyari, M., Popescu, V., Pozzilli, C., Pugliatti, M., et al. (2025) · Frontiers in Immunology

Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms

Cited by 21